Shanghai Eye Disease Prevention & Treatment Center
Shanghai, Shanghai Municipality, 200041, China
NCT Number: NCT06528860
This study aims to evaluate the effectiveness and acceptability of dual-focus soft contact lenses in controlling rapid myopia progression in adults through a randomized controlled trial. By applying myopia control measures to the adult population, we hope to provide scientific evidence for the effective control of adult myopia progression and offer insights into the understanding of myopia progression during early adulthood.
Trial opening soon.
Get Notified18 year–25 year
All sexes
Interventional
Not applicable
Shanghai, Shanghai Municipality, 200041, China
It has long been believed that the progression of myopia mainly occurs during the elementary to high school stages. However, some studies and clinical practice suggest that a considerable proportion of adults still experience myopia progression in their adulthood, especially in those who have prolonged near work or screen usage time. At present, there is insufficient evidence on whether these population needs myopia control intervention. Most adults experiencing myopia progression do not receive appropriate myopic intervention measures, leading to an increase of dioptre, which may affect the quality of daily life, and raise the risk of high myopia and blinding myopia complications.
This study aims to evaluate the effectiveness and acceptability of dual-focus soft contact lenses in controlling rapid myopia progression in adults through a randomized controlled trial. By applying myopia control measures to the adult population, we hope to provide scientific evidence for the effective control of adult myopia progression and offer insights into the understanding of myopia progression during early adulthood.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dual-focus contact lenses, daily disposable, material: omafilcon A, water content: 60%.
Other names: CooperVision
Single-vision contact lenses, daily disposable, material: omafilcon A, water content: 60%.
Other names: CooperVision
Time frame: 2 years after the baseline
The difference in the change of cycloplegic spherical equivalent between the intervention group and the control group.
Time frame: 2 years after the baseline
The difference in the change of axial length between the intervention group and the control group.
Trial opening soon.
Get NotifiedShanghai Eye Disease Prevention and Treatment Center
Other
The Effectiveness and Acceptability of Dual-focus Soft Contact Lenses for Controlling Rapid Progressive Myopia in Young Adults: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07839091
Eye Diseases, Myopia
Singapore
View Trial DetailsNCT07829419
Astigmatism, Eye Diseases
New York, United States
View Trial DetailsNCT07825428
Eye Diseases, Myopia
Guiyang, Guizhou, China
View Trial DetailsNCT07810725
Astigmatism, Eye Diseases
View Trial Details